SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-019874
Filing Date
2022-05-12
Accepted
2022-05-12 16:17:53
Documents
63
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q mtcr-10q_20220331.htm   iXBRL 10-Q 2299016
2 EX-10.1 mtcr-ex101_9.htm EX-10.1 65907
3 EX-31.1 mtcr-ex311_10.htm EX-31.1 22418
4 EX-31.2 mtcr-ex312_7.htm EX-31.2 21423
5 EX-32.1 mtcr-ex321_8.htm EX-32.1 14145
  Complete submission text file 0001564590-22-019874.txt   7721635

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA mtcr-20220331.xsd EX-101.SCH 52009
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE mtcr-20220331_cal.xml EX-101.CAL 39591
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE mtcr-20220331_def.xml EX-101.DEF 149108
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE mtcr-20220331_lab.xml EX-101.LAB 423108
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE mtcr-20220331_pre.xml EX-101.PRE 304598
57 EXTRACTED XBRL INSTANCE DOCUMENT mtcr-10q_20220331_htm.xml XML 1265164
Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 SAN DIEGO CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 SAN DIEGO CA 92037 858-369-7800
Metacrine, Inc. (Filer) CIK: 0001634379 (see all company filings)

IRS No.: 472297384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39512 | Film No.: 22918059
SIC: 2834 Pharmaceutical Preparations